Table 3 Distribution of HCV genotypes across various age group
From: The “hidden” epidemic: a snapshot of Moroccan intravenous drug users
HCV genotype | ||||
|---|---|---|---|---|
Age (n) | 1a | 1b | 3a | 4a |
16-20 (4) | 1 (0.25) | 0 | 3 (0.75) | 0 |
21-25 (7) | 5 (0.71) | 0 | 1 (0.14) | 1 (0.14) |
26-30 (10) | 6 (0.60) | 0 | 3 (0.30) | 1 (0.10) |
31-35 (13) | 7 (0.53) | 1 (0.07) | 1 (0.07) | 4 (0.31) |
36-40 (12) | 7 (0.58) | 2 (0.16) | 3 (0.25) | 0 |
41-45 (11) | 8 (0.73) | 3 (0.27) | 0 | 0 |
46-50 (2) | 2 (1.00) | 0 | 0 | 0 |